Jilin Province Huinan Changlong Pharmaceutical

Jilin Province Huinan Changlong Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacture of Chinese patent medicines and biochemical drugs. The company's product portfolio is primarily focused on therapeutic areas such as cardiovascular and cerebrovascular diseases, digestive system disorders, and musculoskeletal conditions. Key commercial products include Compound Sea-buckthorn Seed Oil Capsules for gastric health and Scutellarin Injection for cerebrovascular conditions. Headquartered in Jilin Province, the company operates GMP-certified manufacturing facilities and distributes its products extensively throughout the Chinese domestic market. It is publicly traded on the GEM of the Hong Kong Stock Exchange, maintaining a business model that bridges traditional herbal medicine with modern biochemical extraction techniques.